at MarketWatch.com (Sep 25, 2012)
Savient Pharmaceuticals (SVNT) announces the formation of an Office of the President, consisting of Richard Crowley, who will serve as Co-President and COO, John P. Hamill, who will serve as Co-President and CFO, and Philip K. Yachmetz, who will serve as Co-President and Chief Business Officer. Savient also says that Louis Ferrari, President, CEO, and Director, is leaving the Company to pursue other interests, effective immediately. Shares -4.3% AH.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at CNBC.com (Sep 19, 2012)
at MarketWatch.com (Jul 11, 2012)
at MarketWatch.com (May 9, 2012)
at MarketWatch.com (Feb 1, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs